<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04687605</url>
  </required_header>
  <id_info>
    <org_study_id>AZ230/14</org_study_id>
    <nct_id>NCT04687605</nct_id>
  </id_info>
  <brief_title>Therapeutic Hypercapnia After Aneurysmal Subarachnoid Hemorrhage - Optimum Duration of Hypercapnia</brief_title>
  <official_title>Therapeutic Hypercapnia After Aneurysmal Subarachnoid Hemorrhage - Study for the Optimum Duration of Hypercapnia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wuerzburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wuerzburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Temporary hypercapnia leads to a reproducible increase of cerebral blood flow (CBF) and brain&#xD;
      tissue oxygenation (StiO2) as shown in a previous study (Trial-Identification: NCT01799525).&#xD;
      The aim of this study now was to measure the course of carbon dioxide partial pressure (pCO2)&#xD;
      reactivity after prolonged hypercapnia, and to evaluate the therapeutic effect of graded&#xD;
      hypercapnia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cerebral vasospasm still is the leading cause of delayed cerebral ischemia (DCI) and&#xD;
      secondary ischemic deficits after aneurysmal subarachnoid hemorrhage (SAH). Hypercapnia leads&#xD;
      to a reproducible increase of cerebral blood flow (CBF) and brain tissue oxygenation (StiO2)&#xD;
      as shown in a previous study (Trial-Identification: NCT01799525). Furthermore, the increase&#xD;
      of CBF and StiO2 sustained after normalization of ventilation and no rebound effect was&#xD;
      found. So, a possible optimization of the hypercapnic period may lead to prolonged effects of&#xD;
      increased CBF and StiO2. Aim of this stuy is to find the ideal duration of hypercapnia and to&#xD;
      evaluate the therapeutic effect of graded hypercapnia. For this, intubated and mechanically&#xD;
      ventilated patients with an aneurysmal SAH Hunt/Hess 3-5, Fisher grade 2-4 on the initial CT&#xD;
      scan and supplied with an external ventricular drainage will be included within the first 96&#xD;
      hours after ictus. Between day 4 and 14 they undergo a trial intervention in which the&#xD;
      respiratory minute volume will be reduced in order to maintain a target PaCO2 of 50 - 55 mmHg&#xD;
      for 2 hours. Arterial blood gas analysis (ABG) and transcranial Doppler sonography (TCD) is&#xD;
      performed in 15-minute intervals. Intracranial pressure (ICP), cerebral perfusion pressure&#xD;
      (CPP), and cardiovascular parameters are monitored continuously, serial measurement of CBF&#xD;
      and StiO2 under continous hypercapnia is performed. Primary endpoint of this trial is change&#xD;
      of CBF under hypercapnia, secondary endpoints are StiO2, measures non-invasively with&#xD;
      near-infrared spectroscopy, mean flow velocity of intracranial vessels in TCD, delayed&#xD;
      cerebral infarction in cranial CT and Glasgow Outcome Score (GOS) after 6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral blood flow (CBF)</measure>
    <time_frame>2-4 hours, day 4-14 after SAH</time_frame>
    <description>Changes of CBF (absolute, ml/100g tissue/min) under changes of arterial pCO2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cerebral tissue oxygen saturation</measure>
    <time_frame>2-4 hours, day 4-14 after SAH</time_frame>
    <description>Changes of tissue oxygen saturation measured by near-infrared spectroscopy (NIRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow Outcome Score (GOS)</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Glasgow Outcome Score (GOS 1 - 5, GOS 1 = Death, GOS 5 = none or low disability) after 14 days, after discharge and 6 months</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Vasospasm Intracranial</condition>
  <arm_group>
    <arm_group_label>Optimum duration of hypercapnia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily serial measurement of 2 hours under target hypercapnia of pCO2 50 - 55 mmHg by changes of respirator settings once per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Temporary hypercapnia</intervention_name>
    <description>Temporary daily hypercapnia for 2 hours between day 4 and 14 after SAH</description>
    <arm_group_label>Optimum duration of hypercapnia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aneurysmal SAH&#xD;
&#xD;
          -  Aneurysm occluded by clipping/coiling within 96 hours&#xD;
&#xD;
          -  Hunt/Hess 3-5&#xD;
&#xD;
          -  Fisher 2-4 on initial CT scan&#xD;
&#xD;
          -  Intubated, sedated and mechanically ventilated patient&#xD;
&#xD;
          -  Continous drainage of cerebrospinal fluid (CSF)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18 years&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Common obstructive lung disease (COLD)&#xD;
&#xD;
          -  potential of hydrogen (pH) in ABG &lt; 7,25&#xD;
&#xD;
          -  ICP &gt; 20 mmHg&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Wuerzburg</investigator_affiliation>
    <investigator_full_name>Dr. Stetter</investigator_full_name>
    <investigator_title>Principial Investigator</investigator_title>
  </responsible_party>
  <keyword>SAH</keyword>
  <keyword>Hypercapnia</keyword>
  <keyword>DCI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

